A study of MGD014 for the treatment of HIV infections
Phase of Trial: Phase I
Latest Information Update: 05 Sep 2017
At a glance
- Drugs MGD 014 (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 05 Sep 2017 According to a MacroGenics media release, the company has submitted an IND for MGD014.
- 11 May 2016 New trial record
- 05 May 2016 According to a MacroGenics media release, the company expects to submit an Investigational New Drug Application (IND) for MGD014 in the year 2017.